Atlas Trials

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients

Clinical trial NCT01258192 · COMPLETED

Trial details

NCT number
NCT01258192
Sponsor
Zhejiang Cancer Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2011-01-01
Primary completion
2012-10-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.